295 related articles for article (PubMed ID: 34172393)
1. Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction.
Liu QK
J Clin Lipidol; 2021; 15(4):556-568. PubMed ID: 34172393
[TBL] [Abstract][Full Text] [Related]
2. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids: JACC Focus Seminar.
Weinberg RL; Brook RD; Rubenfire M; Eagle KA
J Am Coll Cardiol; 2021 Feb; 77(5):593-608. PubMed ID: 33538258
[TBL] [Abstract][Full Text] [Related]
4. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.
Orringer CE; Jacobson TA; Maki KC
J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence.
Bhat S; Sarkar S; Zaffar D; Dandona P; Kalyani RR
Curr Cardiol Rep; 2023 Feb; 25(2):51-65. PubMed ID: 36729217
[TBL] [Abstract][Full Text] [Related]
6. Effect of omega-3 supplements on plasma apolipoprotein C-III concentrations: a systematic review and meta-analysis of randomized controlled trials.
Sahebkar A; Simental-Mendía LE; Mikhailidis DP; Pirro M; Banach M; Sirtori CR; Reiner Ž
Ann Med; 2018 Nov; 50(7):565-575. PubMed ID: 30102092
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-art.
Watanabe Y; Tatsuno I
Expert Rev Clin Pharmacol; 2021 Jan; 14(1):79-93. PubMed ID: 33306922
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease.
Shibabaw T
Mol Cell Biochem; 2021 Feb; 476(2):993-1003. PubMed ID: 33179122
[TBL] [Abstract][Full Text] [Related]
9. [Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis].
Susekov AV
Kardiologiia; 2021 Jul; 61(6):88-96. PubMed ID: 34311692
[TBL] [Abstract][Full Text] [Related]
10. Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis.
Luo S; Hou H; Wang Y; Li Y; Zhang L; Zhang H; Jin Q; Wu G; Wang X
Food Funct; 2024 Feb; 15(3):1208-1222. PubMed ID: 38224465
[No Abstract] [Full Text] [Related]
11. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia.
Dai Perrard XY; Lian Z; Bobotas G; Dicklin MR; Maki KC; Wu H
J Clin Lipidol; 2017; 11(6):1361-1371. PubMed ID: 28942094
[TBL] [Abstract][Full Text] [Related]
12. Dietary and Pharmacological Fatty Acids and Cardiovascular Health.
Wu H; Xu L; Ballantyne CM
J Clin Endocrinol Metab; 2020 Apr; 105(4):1030-45. PubMed ID: 31678992
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acid therapy for cardiovascular disease: justified or not?
Maki KC; Dicklin MR
Curr Opin Cardiol; 2020 Jul; 35(4):417-422. PubMed ID: 32412960
[TBL] [Abstract][Full Text] [Related]
14. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis.
Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS
Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: current status and treatments.
Reyes-Soffer G
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):85-89. PubMed ID: 33481422
[TBL] [Abstract][Full Text] [Related]
16. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
Hussain A; Ballantyne CM; Saeed A; Virani SS
Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 polyunsaturated fatty acids and cardiovascular disease: an emphasis on omega-3-acid ethyl esters 90 for the treatment of hypertriglyceridemia.
Tatsuno I
Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1261-8. PubMed ID: 25319059
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
[TBL] [Abstract][Full Text] [Related]
19. A Novel Anti-Inflammatory Role of Omega-3 PUFAs in Prevention and Treatment of Atherosclerosis and Vascular Cognitive Impairment and Dementia.
Simonetto M; Infante M; Sacco RL; Rundek T; Della-Morte D
Nutrients; 2019 Sep; 11(10):. PubMed ID: 31547601
[TBL] [Abstract][Full Text] [Related]
20. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
